Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 964 | 1,734 | 2,343 | 1,919 | 1,945 |
| Cost of Goods | 903 | 786 | 945 | 797 | 630 |
| Gross Profit | 61 | 948 | 1,397 | 1,122 | 1,316 |
| Operating Expenses | 7,481 | 4,315 | 7,482 | 6,029 | 6,568 |
| Operating Income | -7,420 | -3,367 | -6,085 | -4,907 | -5,252 |
| Interest Expense | 12 | 1 | 0 | 0 | 1 |
| Other Income | 19 | 11 | -9 | -14 | 45 |
| Pre-tax Income | -7,414 | -3,357 | -6,094 | -4,921 | -5,208 |
| Net Income Continuous | -7,414 | -3,357 | -6,094 | -4,921 | -5,208 |
| Net Income | $-7,414 | $-3,357 | $-6,094 | $-4,921 | $-5,208 |
| EPS Basic Total Ops | -0.05 | -0.03 | -0.05 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.05 | -0.03 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.05 | -0.03 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.05 | -0.03 | -0.05 | -0.05 | -0.05 |
| EBITDA(a) | $-7,146 | $-3,133 | $-5,840 | $-4,772 | $-5,072 |